These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial. Li S, Li JP. Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076 [Abstract] [Full Text] [Related]
3. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy. Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G. J Nephrol; 2012 Jan 06; 25(5):810-8. PubMed ID: 22252844 [Abstract] [Full Text] [Related]
5. Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1. Bi X, Yu Y, Zhou S, Zhou Y, Zhao J, Xiong J. Nephron; 2024 Jan 06; 148(9):587-600. PubMed ID: 38723614 [Abstract] [Full Text] [Related]
7. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology. Lin Z, Liu L, Zhang R, Lin X, Lu F, Bao K, Wang L, Lin Q, Mai J, Cao Y, Yang H, Liu X, Zou C. Am J Nephrol; 2021 Jan 06; 52(6):507-518. PubMed ID: 34134110 [Abstract] [Full Text] [Related]
9. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy. Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C. Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712 [Abstract] [Full Text] [Related]
13. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria. Zhong Z, Tang Y, Tan J, Tan L, Pei G, Qin W. Int Urol Nephrol; 2021 Jan 06; 53(1):121-127. PubMed ID: 32944888 [Abstract] [Full Text] [Related]
16. Progression of IgA nephropathy under current therapy regimen in a Chinese population. Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H. Clin J Am Soc Nephrol; 2014 Mar 06; 9(3):484-9. PubMed ID: 24408121 [Abstract] [Full Text] [Related]
17. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation. Shen XH, Liang SS, Chen HM, Le WB, Jiang S, Zeng CH, Zhou ML, Zhang HT, Liu ZH. J Nephrol; 2015 Aug 06; 28(4):441-9. PubMed ID: 25585823 [Abstract] [Full Text] [Related]
18. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, K Smerud H, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E. Pediatr Nephrol; 2017 Jan 06; 32(1):139-150. PubMed ID: 27557557 [Abstract] [Full Text] [Related]
20. Clinical outcomes of IgA nephropathy patients with different proportions of crescents. Zhang W, Zhou Q, Hong L, Chen W, Yang S, Yang Q, Chen W, Yu X. Medicine (Baltimore); 2017 Mar 06; 96(11):e6190. PubMed ID: 28296731 [Abstract] [Full Text] [Related] Page: [Next] [New Search]